UCoptis Chinensis, umhlaza waseShayina wendabuko, unokufumana uncedo lwezempilo
ICoptis chinensis yintlobo esetyenziswa ngamayeza aseShayina . Ngamanye amaxesha kuthiwa i-huang lian okanye i-goldthread, izicatshulwa zeengcambu zeengcambu ziyafumaneka kwifom yokuncedisa ukutya. Ngokuqhelekileyo isetyenziselwa ukuphatha iingxaki zesisu, iCoptis chinensis kuthiwa ukukhusela kwezinye iindlela zesifo somhlaza.
I-Coptis chinensis iqulethe iindidi ezicatshangelwe ukuphucula impilo, kubandakanywa i-berberine (ikhemikhali efunyenwe ukuba ne-antibacterial, anti-antial, kunye ne-anti-inflammatory properties).
Ukusetyenziswa kweCoptis Chinensis
Ngenye iyeza, uCoptis chinensis kuthiwa uncedo ekunyangeni kwezi zimo zempilo ezilandelayo:
- Sikashukela
- Uhudo
- Izifo zentloko
- Isifo sentliziyo
- Igazi elonyukayo
- Cholesterol ephezulu
- Psoriasis
- Izifo zokuphefumula
Ukongeza, iCoptis chinensis icelwa ukuba ikhusele umhlaza kwaye ikhusele isifo sesibindi.
Iinzuzo zeCoptis Chinensis
Kuphando lokuqala olwenziwe kwizilwanyana kunye neeseli zabantu, izazinzulu ziye zafumanisa ukuba iCoptis chinensis inokubonelela ngeentlobo zeempatho zezempilo. Nangona ngoku kungabikho kokuhlolwa kovavanyo lweekliniki uCoptis chinensis kunye nemiphumo yalo yempilo, uphando lubonisa ukuba imifuno ibonisa isithembiso kwiindawo ezithile:
1) Isifo sikashukela
Ininzi yezifundo ezisekelwe kwizilwanyana zibonisa ukuba iCoptis chinensis inokuba nefuthe lokulwa nesifo sikashukela. Ngophando luka-2011 oluvela kwi- American Journal ye-Medicine yaseTshayina , umzekelo, iimvavanyo kwierats zibonise ukuba iCoptis chinensis inokukunceda ukukhusela kwisifo sikashukela, ngokuyinxalenye ngokuphucula ukukhuselwa kwe-insulin .
2) Izifo zentliziyo
I-Coptis chinensis inokusebenza ngokuchasene nesifo senhliziyo, ngokubhekiselele kuphando olushicilelwe kwi- Plant Foods lwe-Human Nutrition ngo-2006. Xa kuhlolwa iigatshi, abalobi boluvo bafumanisa ukuba iCoptis chinensis inokukunceda ukukhusela okanye ukulawula isifo senhliziyo ngokunciphisa i-cholesterol kunye neqondo leshukela legazi .
3) I cancer
Kukho ubungqina bokuba uCoptis chinensis unokufumana iipropati zokulwa nomhlaza. Ngophando luka-2005 olupapashwe kwiCarcinogenesis , umzekelo, iimvavanyo kwiiseli zomntu zityhila ukuba iCoptis chinensis inokunceda ukulwa nomhlaza wesibele ngokunciphisa i-apoptosis (uhlobo lwesifo sokufa esicwangcisiweyo kubalulekile ekunqandeni ukwandiswa kweeseli zomhlaza).
Ukongezelela, isifundo esisekelwe kwiseli esashicilelwe kwi- International Journal of Medicine Molecular ngo-2009 safumanisa ukuba i-pro-apoptotic imiphumo yeCoptis chinensis inokunyusa umzimba ukukhusela umdlavuza wesibindi.
Imijelo
Ngenxa yokungabikho kophando, incinci iyaziwa ngokukhuseleko lwexesha elide okanye eliqhelekileyo leCoptis chinensis. Nangona kunjalo, kukho inkxalabo yokuba ukutya kwe-berberine kunokwandisa amanqanaba ekomidi elibizwa ngokuba yi-bilirubin kubantwana abasandul 'ukuzalwa. Ekubeni amazinga aphakamileyo e-bilirubin adibene nokungasebenzi komzimba kwiintsana ezisanda kuzalwa, kubalulekile ukuphepha ukusetyenziswa kweCoptis chinensis kwiintsana ezisandul 'ukuzalwa.
Oomama abakhulelweyo kunye noomama abancancisayo mabaphephe ukusetyenziswa kweCoptis chinensis.
Ukongezelela, kukho inkxalabo yokuba i-berberine inokulimaza abantu abanesifo senhliziyo.
Hlalani nikhumbule ukuba izongezelelo azange zivavanyelwe ukukhusela kunye nezondlo zokutya zikhululekile.
Kwezinye iimeko, loo mveliso inokuhambisa amaxabiso ahluke kwixabiso elichaziweyo kwiyeza ngalinye. Kwezinye iimeko, loo mveliso inokungcoliswa nezinye izinto ezifana nezitye. Kwakhona, ukhuseleko lwezongezelelo kubasetyhini abakhulelweyo, oomama abangabongikazi, abantwana, kunye nalabo abanezifo zonyango okanye abathabatha imishanguzo ayilwanga.
Eminye iCoptis Chinensis
Ukufumana uncedo ekunciphiseni isifo sikashukela kunye nesifo senhliziyo, kukho iindlela ezininzi zemvelo eziza kunika izibonelelo ezithile.Izi mpawu ziquka ezo zityalo ezifana ne- cinnamon kunye ne- fenugreek , kwakunye ne-anthocyanins (iklasi leemithi ezixhatshazwayo ezifumaneka ngokuqhelekileyo kwi-acai, i- bilberry , i- chokeberry , elderberry , cherry tart kunye nezinye izithelo nemifuno).
Kuphi ukuwufumana
Kuthengiswa kwiindawo ezininzi zokutya ezendalo kunye nezidakamizwa, izibonelelo zokutya eziqukethe iCoptis chinensis nazo zingathengwa ngekhompyutha.
Usebenzisa uCoptis Chinensis wezeMpilo
Ngenxa yophando oluncitshisiweyo, kungekudala ukukhuthaza uCoptis chinensis njengonyango kuyo nayiphi na imeko. Kwakhona kubalulekile ukuba uqaphele ukuba ukuzithobela imeko kwaye ukuphepha okanye ukulibazisa ukunakekelwa okuqhelekileyo kunokuba nemiphumo emibi. Ukuba ucinga ukusebenzisa iCoptis chinensis nayiphi na injongo yezempilo, qiniseka ukuba udibane nodokotela wakho kuqala.
Imithombo
Auyeung KK, Ko JK. "ICoptis chinensis inqanda ukukhushulwa kweesitocellular cell cell kwi-anti-inflammatory anti-inflammatory activation gene." Int J Jol Med. 2009 Oct; 24 (4): 571-7.
Kang JX, Liu J, Wang J, He C, Li FP. "I-extract of huanglian, i-herb medicinal herb, inokubamba ukukhutshwa kweselula kunye ne-apoptosis ngokugqitywa kwe-interferon-beta kunye ne-TNF-alpha kumaseli omhlaza wesifuba somntu." ICarcinogenesis. 2005 Nov; 26 (11): 1934-9.
Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y, Yang D, Liang H, Ye J, Weng J. "I-Berberine iphucula i-glucose metabolism kwiisundu zesifo sikashukela ngokumelana ne-hepatic gluconeogenesis." PLoS One. 2011 Feb 3; 6 (2): e16556.
I Yuan L, Tu D, Ye X, iWu J. "Imiphumo ye-Hypoglycemic kunye ne-hypocholesterolemic yeCoptis chinensis franch inflorescence." Ukutyalwa kweZityalo Ukutya iHum. 2006 uSept; 61 (3): 139-44.
Zhang Q, Piao XL, Piao XS, Lu T, Wang D, Kim SW. "Umphumo wokukhusela weCoptis chinensis kunye ne-berberine ngokulimala kwamathumbu emathunjini kwiingqungquthela ezijongene neepopolysaccharides." Ukutya i-Chem Toxicol. NgoJan 2011; 49 (1): 61-9.
Zhen Z, Chang B, Li M, Lian FM, Chen L, Dong L, Wang J, Yu B, Liu WK, Li XY, Qin PJ, Zhang JH, Tong XL. "Iziphumo zesifo sesifo sikashukela seCoptis chinensis esineenkomfa zorhwebo zaseShayina zolu hlobo ngohlobo lwe-2 ii-rats zesifo sikashukela." Am J Chin Med. 2011; 39 (1): 53-63.